ReviewFrontiers in immunology2026
The gene regulatory networks shaping macrophage plasticity and altered function in fibrosis.
Review in Frontiers in immunology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- Neuroimmune regulation of post-traumatic bone regeneration: focus on inflammatory switching and functional recovery.Frontiers in immunology · 2026Review
- Molecular insights of a Unani formulation in targeting fibrosis-associated diseases.Frontiers in pharmacology · 2026Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Tissue inflammation and its resolution are fundamental physiological processes that ensure homeostasis and tissue integrity following injury. A precise balance between pro-inflammatory and pro-resolving mechanisms promotes proper tissue repair, whereas dysregulation of these pathways results in chronic damage and fibrosis. This complex multicellular phenomenon ultimately manifests in extensive extracellular matrix (ECM) deposition and organ failure. Although the core transcriptional programs are highly conserved throughout evolution and across different species and tissues, distinct features arise under the influence of specific tissue microenvironments. The functionally divergent phenotypes and widespread heterogeneity of macrophages enable them to play a key modulatory role along the inflammation-resolution-fibrosis axis. Recent advances in epigenetic and transcriptomic profiling have revealed novel regulatory circuits and candidate transcriptional regulators governing macrophage phenotypes in fibrotic contexts. In this review, we aim to integrate current knowledge on the complex, context-dependent regulatory mechanisms and dysfunction of macrophages in fibrosis. We highlight the importance of macrophage ontogeny, signal- and metabolism-dependent transcriptional regulation, and chromatin remodeling in disease progression, with particular attention to therapeutic perspectives.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.